Vitaflo Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
300
- Latest Deal Type
-
M&A
- Investors
-
1
Vitaflo General Information
Description
Provider of clinical nutritional products. The company develops specialized clinical nutrition products for metabolic disorders, nutrition support and specific health conditions such as kidney disease. The company sells its products online as well as through mail order.
Contact Information
Website
www.vitaflo.co.ukCorporate Office
- 11 Century Building
- Brunswick Business Park
- Liverpool L3 4BL
- England, United Kingdom
Corporate Office
- 11 Century Building
- Brunswick Business Park
- Liverpool L3 4BL
- England, United Kingdom
Vitaflo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 02-Aug-2010 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 27-May-2008 | Completed | Generating Revenue |
Vitaflo Patents
Vitaflo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025211254-A1 | Treatment of motor disorders in glucose transporter type 1 deficiency syndrome without inducing ketosis | Pending | 26-Jan-2024 | ||
| WO-2025157899-A1 | Treatment of motor disorders in glucose transporter type 1 deficiency syndrome without inducing ketosis | Pending | 26-Jan-2024 | ||
| AU-2018293718-A1 | Combination comprising decanoic acid for the treatment of epilepsy | Active | 29-Jun-2017 | ||
| AU-2018293718-B2 | Combination comprising decanoic acid for the treatment of epilepsy | Active | 29-Jun-2017 | ||
| AU-2024202343-A1 | Combination comprising decanoic acid for the treatment of epilepsy | Active | 29-Jun-2017 | A61K31/20 |
Vitaflo Signals
Vitaflo Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MSIF | Venture Capital | Minority | ||
| Virgin Money UK | Corporation | Minority |
Vitaflo Investments (1)
Vitaflo’s most recent deal was a Corporate Asset Purchase with Dr. Schär (Mevalia and ComidaMed Brands and Manufacturing Facility in Rosbach, Germany). The deal was made on 08-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dr. Schär (Mevalia and ComidaMed Brands and Manufacturing Facility in Rosbach, Germany) | 08-Jun-2021 | Corporate Asset Purchase | Buildings and Property |
Vitaflo FAQs
-
When was Vitaflo founded?
Vitaflo was founded in 1997.
-
Where is Vitaflo headquartered?
Vitaflo is headquartered in Liverpool, United Kingdom.
-
What is the size of Vitaflo?
Vitaflo has 300 total employees.
-
What industry is Vitaflo in?
Vitaflo’s primary industry is Other Healthcare Services.
-
Is Vitaflo a private or public company?
Vitaflo is a Private company.
-
What is Vitaflo’s current revenue?
The current revenue for Vitaflo is .
-
How much funding has Vitaflo raised over time?
Vitaflo has raised $31.4M.
-
Who are Vitaflo’s investors?
MSIF and Virgin Money UK have invested in Vitaflo.
-
When was Vitaflo acquired?
Vitaflo was acquired on 02-Aug-2010.
-
Who acquired Vitaflo?
Vitaflo was acquired by Nestlé Health Science.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process